EEG SLEEP PATTERNS IN PARKINSONIAN PATIENTS TREATED WITH BROMOCRYPTINE AND L-DOPA: A COMPARATIVE STUDYVARDI J; GLAUBMAN H; RABEY J et al.1979; J. NEUR. TRANSM.; AUT; DA. 1979; VOL. 45; NO 4; PP. 307-316; BIBL. 4 P.Article

EEG SLEEP STUDY IN PARKINSONIAN PATIENTS UNDER BROMOCRYPTINE TREATMENTRABEY J; VARDI J; GLAUBMAN H et al.1978; EUROP. NEUROL.; CHE; DA. 1978; VOL. 17; NO 6; PP. 345-350; BIBL. 2 P.Article

Efficacyof memantine, an NMDA receptor antagonist, in the treatment of Parkinson's diseaseRABEY, J. M; NISSIPEANU, P; KORCZYN, A. D et al.Journal of neural transmission - Parkinson's disease and dementia section. 1992, Vol 4, Num 4, pp 277-282, issn 0936-3076Article

Cholinergic muscarinic binding by human lymphocytes: changes with aging, antagonist treatment, and senile dementia of the Alzheimer typeRABEY, J. M; SHENKMAN, L; GILAD, G. M et al.Annals of neurology. 1986, Vol 20, Num 5, pp 628-631, issn 0364-5134Article

The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementiaWERBER, E. A; RABEY, J. M.Journal of neural transmission. 2001, Vol 108, Num 11, pp 1319-1325, issn 0300-9564Article

Cholinergic muscarinic binding by rat lymphocytes: effects of antagonist treatment, strain and agingSHENKMAN, L; RABEY, J. M; GILAD, G. M et al.Brain research. 1986, Vol 380, Num 2, pp 303-308, issn 0006-8993Article

Beneficial effect of cabergoline, new long-lasting D₂ agonist in the treatment of Parkinson's diseaseRABEY, J. M; NISSIPEANU, P; INZELBERG, R et al.Clinical neuropharmacology. 1994, Vol 17, Num 3, pp 286-293, issn 0362-5664Article

[³H] dopamine uptake by platelet storage granules in Parkinson's diseaseRABEY, J. M; SHABTAI, H; GRAFF, E et al.Life sciences (1973). 1993, Vol 53, Num 23, pp 1753-1759, issn 0024-3205Article

Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stressGILAD, G. M; RABEY, J. M; GILAD, V. H et al.Life sciences (1973). 1987, Vol 40, Num 25, pp 2401-2408, issn 0024-3205Article

Posterior fossa lesions associated with neuropsychiatric symptomatologyPOLLAK, L; KLEIN, C; RABEY, J. M et al.International journal of neuroscience. 1996, Vol 87, Num 3-4, pp 119-126, issn 0020-7454Article

Selective influence of rat genotype on age-related regional changes in forebrain muscarinic bindingGILAD, G. M; RABEY, J. M; SHENKMAN, L et al.Neurobiology of aging. 1987, Vol 8, Num 6, pp 517-520, issn 0197-4580Article

Neurosurgical intervention for cervical disk disease in dystonic cerebral palsyPOLLAK, L; SCHIFFER, J; KLEIN, C et al.Movement disorders. 1998, Vol 13, Num 4, pp 713-717, issn 0885-3185Article

Electroencephalographic findings with low-dose clozapine treatment in psychotic parkinsonian patientsNEUFELD, M. Y; RABEY, J. M; ORLOV, E et al.Clinical neuropharmacology. 1996, Vol 19, Num 1, pp 81-86, issn 0362-5664Article

[³H]dopamine uptake by platelet storage granules in schizophreniaRABEY, J. M; LERNER, A; SIGAL, M et al.Life sciences (1973). 1992, Vol 50, Num 1, pp 65-72, issn 0024-3205Article

Age-dependent loss and compensatory changes of septohippocampal cholinergic neurons in two rat strains differing in longevity and response to stressGILAD, G. M; RABEY, J. M; TIZABI, Y et al.Brain research. 1987, Vol 436, Num 2, pp 311-322, issn 0006-8993Article

The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patientsWERBER, E. A; GANDELMAN-MARTON, R; KLEIN, C et al.Journal of neural transmission. 2003, Vol 110, Num 6, pp 659-669, issn 0300-9564, 11 p.Article

Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of ratsRABEY, J. M; GRAFF, E; OBERMAN, Z et al.Acta neurologica scandinavica. 1986, Vol 74, Num 4, pp 289-292, issn 0001-6314Article

Effect of various neuroactive drugs on bromocriptine concentration in the striatum of ratsVARDI, J; GRAFF, E; OBERMAN, Z et al.Israel journal of medical sciences. 1984, Vol 20, Num 5, pp 407-409, issn 0021-2180Article

Dopamine uptake by platelet storage granules in first-degree relatives of tourette's syndrome patientsRABEY, J. M; AMIR, I; TREVES, T. A et al.Biological psychiatry (1969). 1998, Vol 44, Num 11, pp 1166-1170, issn 0006-3223Article

Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's diseaseRABEY, J. M; TREVES, T. A; NEUFELD, M. Y et al.Neurology. 1995, Vol 45, Num 3, pp 432-434, issn 0028-3878, 1Article

Broad bean (Vicia faba) consumption and Parkinson's diseaseRABEY, J. M; VERED, Y; SHABTAI, H et al.Advances in neurology. 1993, Vol 60, pp 681-684, issn 0091-3952Article

Improvement of Parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumptionRABEY, J. M; VERED, Y; SHABTAI, H et al.Journal of neurology, neurosurgery and psychiatry. 1992, Vol 55, Num 8, pp 725-727, issn 0022-3050Article

Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson's dementiaRABEY, J. M; SCHARF, M; OBERMAN, Z et al.Biological psychiatry (1969). 1990, Vol 27, Num 6, pp 581-591, issn 0006-3223Article

Bromocriptine blood levels after the concomitant administration of levodopa, amantadine and biperiden in Parkinson's diseaseRABEY, J. M; OBERMAN, Z; SCHARF, M et al.Acta neurologica scandinavica. 1990, Vol 81, Num 5, pp 411-415, issn 0001-6314, 5 p.Article

The influence oe Levodopa in the pharmacokinetics of bromocriptine in Parkinson's diseaseRABEY, J. M; OBERMAN, Z; SCHARF, M et al.Clinical neuropharmacology. 1989, Vol 12, Num 5, pp 440-447, issn 0362-5664Article